About WaferGen Bio-systems
WaferGen Bio-systems, Inc. (WaferGen) is engaged in the development, manufacture and sale of genomic technology solutions for single-cell analysis (SCA) and clinical research. The Company focuses on marketing an open format genetic analysis system, the WaferGen SmartChip System. The Company's ICELL8 Single-Cell System is a platform that can isolate a range of single cells and process specific cells for analysis, including Next Generation Sequencing (NGS). ICELL8 is based upon the Company's SmartChip platform, which is also used for profiling and validating molecular biomarkers. The Company's SmartChip is a micro-fabricated chip comprising a range of massively-parallel micro wells that are physically separated from each other. It offers SmartChip System Capabilities, SmartChip Single-Cell Isolation System, SmartChip Target Enrichment (TE) System and Apollo 324 Library Preparation.
Industry, Sector and Symbol:
- Sector: Medical
- Industry: Medical Laboratories & Research
- Sub-Industry: N/A
- Exchange: NASDAQ
- Symbol: WGBS
- Previous Close: $6.80
- 50 Day Moving Average: $5.74
- 200 Day Moving Average: $2.78
- 52-Week Range: $2.50 - $6.90
- Trailing P/E Ratio: N/A
- Foreward P/E Ratio: -3.73
- P/E Growth: 0.00
- Market Cap: $25.70M
- Outstanding Shares: 3,785,000
- Beta: 1.29
- Net Margins: -225.65%
- Return on Equity: -221.83%
- Return on Assets: -95.23%
Companies Related to WaferGen Bio-systems:
- Debt-to-Equity Ratio: 1.90%
- Current Ratio: 1.82%
- Quick Ratio: 1.53%
What is WaferGen Bio-systems' stock symbol?
WaferGen Bio-systems trades on the NASDAQ under the ticker symbol "WGBS."
Where is WaferGen Bio-systems' stock going? Where will WaferGen Bio-systems' stock price be in 2017?
1 brokers have issued 12-month price targets for WaferGen Bio-systems' shares. Their predictions range from $5.00 to $5.00. On average, they anticipate WaferGen Bio-systems' share price to reach $5.00 in the next twelve months.
When will WaferGen Bio-systems announce their earnings?
WaferGen Bio-systems is scheduled to release their next quarterly earnings announcement on Monday, March, 6th 2017.
Who owns WaferGen Bio-systems stock?
WaferGen Bio-systems' stock is owned by many different of retail and institutional investors. Top institutional shareholders include Opaleye Management Inc (5.26%), Opaleye Management Inc (5.14%), Sabby Healthcare Master Fund, Ltd (9.99%) and Opaleye Management Inc. (8.45%).
Who bought WaferGen Bio-systems stock? Who is buying WaferGen Bio-systems stock?
WaferGen Bio-systems' stock was acquired by a variety of institutional investors in the last quarter, including Opaleye Management Inc..
How do I buy WaferGen Bio-systems stock?
Shares of WaferGen Bio-systems can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.
How much does a share of WaferGen Bio-systems stock cost?
One share of WaferGen Bio-systems stock can currently be purchased for approximately $6.90.